SARS‑CoV‑2-induced remission of advanced classical Hodgkin lymphoma
Pol Arch Intern Med
.
2022 Aug 22;132(7-8):16266.
doi: 10.20452/pamw.16266.
Epub 2022 May 25.
Authors
Michał Kurlapski
1
,
Grzegorz Romanowicz
2
,
Michał Taszner
1
,
Jan M Zaucha
3
Affiliations
1
Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland
2
Department of Nuclear Medicine, Medical University of Gdansk, Gdańsk, Poland
3
Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland. jzaucha@gumed.edu.pl
PMID:
35620893
DOI:
10.20452/pamw.16266
No abstract available
MeSH terms
COVID-19*
Hodgkin Disease* / drug therapy
Humans
SARS-CoV-2